Legal & General Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,668
Closed -$367K 3554
2024
Q1
$367K Hold
8,668
﹤0.01% 2545
2023
Q4
$362K Buy
8,668
+400
+5% +$16.7K ﹤0.01% 2570
2023
Q3
$312K Sell
8,268
-105
-1% -$3.96K ﹤0.01% 2617
2023
Q2
$318K Buy
8,373
+1,641
+24% +$62.2K ﹤0.01% 2615
2023
Q1
$164K Hold
6,732
﹤0.01% 2653
2022
Q4
$195K Buy
6,732
+339
+5% +$9.85K ﹤0.01% 2614
2022
Q3
$192K Sell
6,393
-40
-0.6% -$1.2K ﹤0.01% 2649
2022
Q2
$233K Sell
6,433
-490
-7% -$17.7K ﹤0.01% 2576
2022
Q1
$299K Buy
6,923
+1,464
+27% +$63.2K ﹤0.01% 2541
2021
Q4
$274K Sell
5,459
-56
-1% -$2.81K ﹤0.01% 2591
2021
Q3
$351K Buy
5,515
+50
+0.9% +$3.18K ﹤0.01% 2522
2021
Q2
$394K Sell
5,465
-55
-1% -$3.97K ﹤0.01% 2382
2021
Q1
$407K Sell
5,520
-58
-1% -$4.28K ﹤0.01% 2330
2020
Q4
$410K Buy
5,578
+634
+13% +$46.6K ﹤0.01% 2296
2020
Q3
$271K Sell
4,944
-9
-0.2% -$493 ﹤0.01% 2311
2020
Q2
$329K Hold
4,953
﹤0.01% 2262
2020
Q1
$303K Hold
4,953
﹤0.01% 2193
2019
Q4
$436K Sell
4,953
-473
-9% -$41.6K ﹤0.01% 2243
2019
Q3
$409K Hold
5,426
﹤0.01% 2198
2019
Q2
$463K Hold
5,426
﹤0.01% 2162
2019
Q1
$586K Buy
5,426
+496
+10% +$53.6K ﹤0.01% 2121
2018
Q4
$417K Buy
4,930
+1,862
+61% +$157K ﹤0.01% 2157
2018
Q3
$302K Hold
3,068
﹤0.01% 2245
2018
Q2
$355K Sell
3,068
-353
-10% -$40.8K ﹤0.01% 2183
2018
Q1
$338K Buy
3,421
+81
+2% +$8K ﹤0.01% 2204
2017
Q4
$350K Sell
3,340
-6,571
-66% -$689K ﹤0.01% 2176
2017
Q3
$1.12M Buy
9,911
+1,593
+19% +$180K ﹤0.01% 1824
2017
Q2
$932K Buy
8,318
+370
+5% +$41.5K ﹤0.01% 1850
2017
Q1
$927K Buy
7,948
+131
+2% +$15.3K ﹤0.01% 1824
2016
Q4
$823K Buy
+7,817
New +$823K ﹤0.01% 1819